Search Orphan Drug Designations and Approvals
-
Generic Name: | Iloprost solution for infusion |
---|---|
Date Designated: | 09/21/1989 |
Orphan Designation: | Treatment of Raynaud's phenomenon secondary to systemic sclerosis. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Berlex Laboratories, Inc. 300 Fairfield Road Wayne, New Jersey 07470 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-